OncoSec Presents Update on PISCES/KEYNOTE-695 Phase 2b Registration-Directed Clinical Trial in Combination with Merck's KEYTRUDA® for Metastatic Melanoma at the ASCO 2018 Annual Meeting
Stock Information for OncoSec Medical Incorporated
Loading
Please wait while we load your information from QuoteMedia.